Neurocrine Biosciences: NBI-921352

The Cute Syndrome Foundation is thrilled to announce that Neurocrine Biosciences' SCN8A study is now up on clinicaltrials.gov.

This is a study to evaluate NBI-921352 as adjunctive therapy in subjects with SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) in patients age 12-21. This is the first SCN8A specific clinical trial and is a huge step forward for our community! Click the link above to learn more about inclusion and exclusion criteria.

To learn more about this study, you or your doctor may contact the study research staff:
Neurocrine Medical Information Call Center
877-641-3461
medinfo@neurocrine.com
ClinicalTrials.gov identifier (NCT number): NCT04873869

​Trial Sites

(More sites to come)
Cook Children's Hospital—Fort Worth, TX
  • ​For more information about the trial, or to determine your child’s eligibility for enrollment, contact Cook Children’s trial investigators at 682-885-2844.